skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

S172 Risk Factors of Clostridium difficile Infection in Helicobacter pylori Diagnosed Patients: A Multicenter Study

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e125-e125 [Peer Reviewed Journal]

2022 by The American College of Gastroenterology ;ISSN: 0002-9270 ;EISSN: 1572-0241 ;DOI: 10.14309/01.ajg.0000857328.45281.64

Full text available

Citations Cited by
  • Title:
    S172 Risk Factors of Clostridium difficile Infection in Helicobacter pylori Diagnosed Patients: A Multicenter Study
  • Author: Pandey, Samiksha ; Tennant, Tamera ; Pokhrel, Ashbina ; Aneese, Andrew ; Halalau, Alexandra
  • Subjects: Gastroenterology ; Infections ; Risk factors
  • Is Part Of: The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e125-e125
  • Description: Methods: A retrospective study was performed in the adult population diagnosed with H. pylori within the Beaumont Hospital system in Michigan, from 2010 to 2021. Inclusion criteria included age > 18 years and diagnosis of H. pylori with one of three proven methods: endoscopic biopsy with pathology, stool antigen test or urea breath test. In a case control analysis for CDI within 6 months of H. pyloridiagnosis, matched for 10-year age interval, sex and 3-unit BMI intervals with those without CDI, 23 (41.1%) vs 17 (30.4%) had been prescribed an antibiotic known to be associated with CDI, 5 (8.9%) vs 4 (7.1%) had been prescribed a histamine receptor 2 (H2) blocker, and 30 (53.6%) vs 29 (51.8%) had been prescribed a proton pump inhibitor (PPI).
  • Publisher: New York: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
  • Language: English
  • Identifier: ISSN: 0002-9270
    EISSN: 1572-0241
    DOI: 10.14309/01.ajg.0000857328.45281.64
  • Source: ProQuest Central

Searching Remote Databases, Please Wait